MENU
LGVN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Longeveron (LGVN) Earnings Date & Reports
Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs... Show more
A.I. Advisor
published Earnings
LGVN is expected to report earnings to fall 10.53% to -170 cents per share on November 06
Q3'26
Est.
$-1.70
Q2'26
Missed
by $0.10
Q1'26
Beat
by $0.13
Q4'25
Missed
by $0.04
Q3'25
Missed
by $0.18
The last earnings report on August 12 showed earnings per share of -189 cents, missing the estimate of -179 cents. With 12.36K shares outstanding, the current market capitalization sits at 21.30M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Details
Industry
N/A
Address
1951 NW 7th Avenue
Phone
+1 305 909-0840
Employees
38
Web
https://www.longeveron.com